All blog posts
Showing 24 out of 90 results
30 四月 2025
EU Regulatory Reform for Medicinal Products: Review of new regulatory exclusivities
18 三月 2025
Navigating competition law and FDI regulation in the pharmaceuticals sector - 2025 Outlook
10 二月 2025
Key Takeaways from the UPC Litigation Forum and Pharma & Biotech Patent Litigation Europe Summit 2025
30 一月 2025
The UPC at 18 months
29 一月 2025
Could we…and would we..? UK CoA confirms that it is bound by previous precedent on second medical use SPCs
29 一月 2025
Transparency at the UPC – accessing information, pleadings and evidence
19 十一月 2024
Sustainability - trends and developments life sciences companies should be aware of
01 十一月 2024
EU Commission fines Teva €462.6 million for misuse of divisional patents and disparagement campaign
11 十月 2024
The new UK Regulatory Innovation Office – a step in the right direction for UK life sciences
04 九月 2024
CJEU finds EC's recent policy of referrals for deals below the merger thresholds illegal - more certainty for companies doing deals?
15 八月 2024
H1 2024 – a steady start for biopharma M&A
07 八月 2024
A new Labour Government – what might this mean for the UK life sciences industry?
Showing 24 out of 90 results
View moreKey contacts
Laura Orlando
Managing Partner, Milan Office, Milan
Alan Montgomery
Partner, Head of Pharmaceuticals Sector, Chair of India Group, London and India Group
Chris Parker KC
Partner, Head of Pharmaceuticals Sector, London and Africa Group